ROS-generating NADPH oxidase NOX4 is a critical mediator in oncogenic H-Ras-induced DNA damage and subsequent senescence by Weyemi, U et al.
ORIGINAL ARTICLE
ROS-generating NADPH oxidase NOX4 is a critical mediator in
oncogenic H-Ras-induced DNA damage and subsequent senescence
U Weyemi
1,2,3, O Lagente-Chevallier
1,2,3, M Boufraqech
1,2,3, F Prenois
1,2,3, F Courtin
1,2,3,
B Caillou
3, M Talbot
1,3, M Dardalhon
2,4, A Al Ghuzlan
1,3, J-M Bidart
1,2,3,
M Schlumberger
1,2,3 and C Dupuy
1,2,3
1University Paris-Sud, Orsay, France;
2UMR 8200 CNRS, Villejuif, France;
3Institut Gustave Roussy, Villejuif, France
and
4Institut Curie section Recherche, UMR 3348 CNRS, Orsay, France
Activated Ras oncogene induces DNA-damage response
by triggering reactive oxygen species (ROS) production
and this is critical for oncogene-induced senescence. Until
now, little connections between oncogene expression,
ROS-generating NADPH oxidases and DNA-damage
response have emerged from different studies. Here we
report that H-RasV12 positively regulates the NADPH
oxidase system NOX4-p22
phox that produces H2O2.
Knocking down the NADPH oxidase with small inter-
ference RNA decreases H-RasV12-induced DNA-damage
response detected by c-H2A.X foci analysis. Using
HyPer, a speciﬁc probe for H2O2, we detected an increase
in H2O2 in the nucleus correlated with NOX4-p22
phox
perinuclear localization. DNA damage response can be
caused not only by H-RasV12-driven accumulation of
ROS but also by a replicative stress due to a sustained
oncogenic signal. Interestingly, NOX4 downregulation by
siRNA abrogated H-RasV12 regulation of CDC6 expres-
sion, an essential regulator of DNA replication. More-
over, senescence markers, such as senescence-associated
heterochromatin foci, PML bodies, HP1b foci and p21
expression, induced under H-RasV12 activation were
decreased with NOX4 inactivation. Taken together, our
data indicate that NADPH oxidase NOX4 is a critical
mediator in oncogenic H-RasV12-induced DNA-damage
response and subsequent senescence.
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published online 15 August 2011
Keywords: oncogenic H-RasV12; ROS; NADPH
oxidase NOX4; DNA damage; senescence
Introduction
Studies in normal cells have shown that forced expres-
sion of oncogenic H-Ras can induce a senescence-like
permanent growth arrest (Serrano et al., 1997; Lin et al.,
1998; Lin and Lowe, 2001). Senescence was initially
identiﬁed as a response of tissue culture cells to activated
oncogene, but its relevance to human cancer has
been demonstrated in preneoplasia with expression of
DNA damage response markers (Bartkova et al., 2005;
Gorgoulis et al., 2005). Indeed, DNA damage signalling
contributes to oncogene-induced senescence (Mallette
et al., 2007). The fact that senescence is more common in
preneoplasia than in neoplasia indicates that senescence
might serve as a barrier to oncogenesis (Bartkova et al.,
2005).
The mechanism by which deregulated oncogenes
induce DNA damage remains unclear, and may arise
from distinct mechanisms that vary depending on the
speciﬁc oncogene, the level of oncogene expression and
cellular context. One possibility is that the DNA damage
response is triggered by excessive replication caused by a
sustained oncogenic signal (Bartkova et al., 2006; Di
Micco et al., 2006). In this case, senescent cells present
an increased number of active replicons and exhibit
defects in DNA replication fork progression (Di Micco
et al., 2006). Another possible mechanism involves
increased cellular levels of reactive oxygen species
(ROS) that will cause DNA damage, such as guanine
oxidation, single- and double-strand breaks. This is in
accordance with the fact that Ras-expressing cells either
cultured in low oxygen condition or treated with a
hydrogen peroxide scavenging agent, such as N-acetyl
cysteine (NAC), blocked Ras-induced senescence (Lee
et al., 1999; Vafa et al., 2002). H-Ras can induce ROS
production (Leikam et al., 2008). However, the mechan-
ism through which Ras expression triggers a rise in ROS
levels within cells, and how ROS function in the case of
Ras-induced senescence remain unclear.
For a long time ROS, except those produced by the
NADPH oxidase of phagocytes, were considered as
metabolic by-products whose degradation is ensured by
various antioxidant enzymatic systems. However, they
are currently also seen as intra- and extracellular
messengers whose production must be sharply con-
trolled. This concept was reinforced since 1999 by the
discovery of six new NADPH oxidases whose single
function is to produce ROS. They constitute a new
family of enzymes known as NOX/DUOX (Bedard and
Krause, 2007), found at different cell locations and
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have shown that overexpression of human NOX1
complex in mammalian cells or activation of the catalytic
subunit of the leucocyte NADPH oxidase NOX2 by the
Epstein–Barr virus nuclear antigen-1 in B cells induced
DNA damage and genomic instability (Chiera et al.,
2008; Gruhne et al., 2009). Although NADPH oxidases
were recently found to induce premature senescent
growth arrest in primary endothelial cells (Schilder
et al., 2009, Lener et al., 2009), their role in oncogene-
induced senescence has not yet been established.
Oncogenic Ras is believed to have roles in the
initiation and progression of thyroid tumors, based on
the high frequency of Ras mutations in benign and
malignant thyroid tumors (Suarez et al., 1990; Tallini,
2002). To investigate the role of ROS-generating
NADPH oxidases in oncogene-induced DNA damage
response, we established a conditional expression of
H-RasV12 under the control of doxycycline in human
non-tumoral thyroid cell line (HThy-ori3.1). Using this
system, we found that NOX4 has a critical role in DNA-
damage response induced by oncogenic H-Ras.
Results
Oncogenic H-RasV12 positively regulates
ROS-generating NADPH oxidase
In a recent study, we highlighted that the NADPH
oxidase NOX4 and its functional partner p22
phox are
expressed inside human thyrocytes (Weyemi et al.,
2010). To investigate whether NOX4 is regulated by
oncogenic Ras, we transduced human thyrocytes with
expression vector carrying cDNA for H-RasV12. As
shown in Figure 1a, NOX4 protein level was upregu-
lated in response to H-RasV12. To investigate the
mechanism of this regulation, we wondered whether H-
RasV12 expression is directly involved in the transcrip-
tional regulation of NOX4. The time course of the effect
of H-RasV12 on NOX4 mRNA expression was done by
real-time (RT)–qPCR. Figure 1b shows that over-
expression of the activated oncogene induced an
increase in NOX4 (2–35-fold) mRNA levels with a
greater variation between 24 and 36h.
We analyzed the expression of the NADPH oxidase in
HThy-ori. As shown by RT–PCR analysis (Figure 2a),
NOX4 gene is also expressed in HThy-ori cell line where
its functional partner p22
phox is detected. Transduction
of HThy-ori cells with H-RasV12 vector preferentially
resulted in upregulation of NOX4 mRNA levels when
compared with other NOX/DUOX mRNA levels as
evaluated by RT–qPCR. In addition, p22
phox protein
level was upregulated in this condition as shown by
immunoﬂuorescence and western blot analysis
(Figure 2b). As expected, Nox4 protein level was also
induced in this condition (Figure 2b). These results
prompted us to perform a doxycycline-inducible expres-
sion system in HThy-ori cells for conditional expression
of H-RasV12. Two of clones had a high level of
expression after induction and showed a refringent
morphology upon doxycycline treatment for 48h
(Supplementary Figure S1). The time course of doxycycline
assays showed that H-RasV12 expression upregulated
NOX4 and p22
phox protein levels (Figure 2c). Immuno-
histochemistry analysis conﬁrmed the induction of
NOX4 expression in these conditions (Figure 2d).
Doxycycline treatment by itself did not induce NOX4
expression in original HThy-ori cells (Figure 2e).
Activated Ras oncogene promotes H2O2 generation via
NADPH oxidase NOX4
Induction of H-RasV12 expression by doxycycline in
HThy-ori cells was also accompanied by an increase in
ROS levels as determined by ﬂow cytometry analysis of
DCFHDA oxidation (Figure 3a). Knocking down
NOX4 with speciﬁc siRNA reduced the levels of ROS
in H-RasV12-inducible cells (Figure 3a) indicating that
the activated oncogene triggered ROS production via
NOX4 regulation. In addition, treatment of cells with
NAC, an antioxidant speciﬁc for H2O2, affected ROS
levels measured in these conditions. A genetically
encoded highly speciﬁc ﬂuorescent probe has been
recently developed for detecting H2O2 inside living cells
(Belousov et al., 2006). This indicator, named HyPer,
has been shown to have submicromolar afﬁnity to H2O2
and to be insensitive to other oxidants. Using the
mammalian expression vectors encoding nuclear-tar-
geted HyPer, we visualized changes in the ﬂuorescence
of HyPer in nucleus upon doxycycline treatment for
24h. This result indicated that H-RasV12 regulated the
H2O2 production near or inside the nucleus (Figure 3b).
Figure 1 H-RasV12 regulates NOX4 in human thyrocytes. (a)
Time-dependant induction of NOX4 by H-Ras in human
thyrocytes. Primary human thyrocytes were maintained in 5H
medium and transduced with H-RasV12-expressing vector. NOX4
protein was analyzed in western blot as described in Materials and
methods. b-Actin was used as loading control. (b) NOX4 mRNA
was quantiﬁed by RT–PCR. Expression values (y-axis) are
displayed on base 2 logarithmic scale.
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OncogeneNuclear expression of Hyper was conﬁrmed by im-
munoﬂuorescence using anti-green ﬂuorescent protein
that speciﬁcally recognized this protein as shown by
immunoblot analysis (Figure 3b). In line with this site of
H2O2 production, we used confocal immunoﬂuores-
cence to determine the respective locations of NOX4
and p22
phox (Figure 3c). A weak co-staining with lamin
A/C, a nuclear membrane marker, was found in the
nucleus of H-RasV12-inducible cells, and a strong co-
staining with calreticulin revealed endoplasmic reticu-
lum localization. NOX4 was detected in comparable
locations (Figure 3c). Nuclei isolation experiments
provided support for nuclear localization for NOX4.
Of interest, as shown previously (Hilenski et al, 2004),
two NOX4 isoforms were thus detected; the 65kDa
form exclusively found in the nuclear fraction and the
75kDa form found in the detergent-insoluble non-
nuclear fraction containing the endoplasmic reticulum
(Figure 3d) Overall, these data indicated that NOX4 and
p22
phox, found to be expressed in nuclear and in
perinuclear compartment of H-RasV12-expressing cells,
form a functional complex that generates H2O2 in the
nucleus environment.
H-RasV12 activation is sufﬁcient for DNA damage
induction
ROS induce DNA damage in different systems (Chiera
et al., 2008; Leikam et al., 2008). Oncogenic Ras triggers
Figure 2 H-RasV12 regulates NOX4-p22
phox system in human thyroid cells HThy-ori. (a) Expression of NOXs in HThy-ori3.1 by
RT–PCR. Lane M, DNA size markers; lane 1, NOX1; lane 2, NOX2; lane 3, NOX3; lane 4, NOX4 and lane 5, NOX5. Expression of
p22
phox was also analyzed by RT–PCR. Human thyrocytes were used as positive control with mRNA expression of markers of thyroid
differentiation as TSH receptor (TSHR), thyroglobuline (Tg), transcription factor PAX8, thyroperoxidase (TPO) and symporter Na
þ/
I
  (NIS). Expression of G3PDH is reported as internal control. Comparative expression of NOX homologues genes in HThy-ori cells
transduced with H-RasV12, analyzed by real-time quantitative reverse transcription–PCR. (b) Immunoﬂuorescence staining of p22
phox
in Hthy-ori3.1 cells transduced for 48h with H-RasV12 or empty vector. Nuclei were stained with DAPI (4’,6-diamidino-2-
phenylindole). Magniﬁcation  63. Western blot analysis of NOX4 and p22
phox in HThy-ori cells transduced for 48h with H-RasV12.
(c) Time-dependent induction of NOX4 and p22
phox upon H-RasV12-inducible expression with doxycycline (1mg/ml). b-Actin was used
as loading control. (d) Immunohistochemical analysis of formalin-ﬁxed parafﬁn-embedded HRasV12-inducible HThy-ori and NOX4-
inducible HEK293 cells treated for 48h with doxycycline (1mg/ml). (e) Western blot analysis of NOX4 in original HThy-ori cells
treated or not with doxycycline (1mg/ml) for 48h.
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OncogeneDNA damage-response signal activation (Bartkova
et al., 2006; Di Micco et al., 2006) and H2O2 is an
important mediator in Ras-induced DNA damage
(Mallette et al., 2007). The phosphorylated form of
histone (g-H2AX) at serine 139 is generally used as a
marker of DNA double-strand breaks (Gorgoulis et al.,
Figure 3 H-RasV12 increases levels of intracellular ROS via NOX4 activity. (a) The intracellular level of ROS was measured in Tet-on-
regulated H-RasV12 HThy-ori cells by DCF ﬂuorescence using ﬂow cytometry. Before treatment with doxycycline (1mg/ml) for 48h, cells
were transduced with short interfering RNAs to NOX4 or treated for 30min with 5mM NAC. Graphs show the quantiﬁcation of
ﬂuorescence mean. Immunoblot detection of NOX4 in HThy-ori cells transduced with siRNA control and siRNA NOX4 SMARTpool,
as control. Values are the means±s.e. from independent experiments, *Po0.05, **Po0.01. (b) HyPer response to H-RasV12 induction.
Confocal analysis of H2O2-dependent ﬂuorescence in Tet-on-regulated H-RasV12 HThy-ori cells-expressing pHyPer-nuc. Magniﬁcation
 20. Western blot and immunoﬂuorescence analysis of Hyper-nuc transduced in H-RasV12-inducible cells using anti-green ﬂuorescent
protein. Magniﬁcation  63. (c) Colocalization between nucleus membrane protein (laminA/C), endoplasmic reticulum marker
(calreticulin), NOX4 and p22
phox by immunoﬂuorescence in cells transduced with H-RasV12-expressing vector. Magniﬁcation  63. The
nuclei were stained with DAPI (4’,6-diamidino-2-phenylindole; blue). (d) Immunoblot detection of NOX4 protein in nuclear fraction
(500g pellet, Nu) and insoluble non-nuclear fraction (200000g pellet, non-Nu) of Tet-on-regulated H-RasV12 HThy-ori cells treated with
or without doxycycline (1mg/ml) for 48h. Nucleus were stained with DAPI and visualized on microscopy. Magniﬁcation  20.
The distribution of NOX4 in non-nuclear and nuclear fractions was characterized using antibodies against fraction-speciﬁc proteins:
lamin A/C for nuclear fraction and calreticulin for reticulum-enriched insoluble non-nuclear fraction.
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Oncogene2005, Nuciforo et al., 2007). The HThy-ori cells
expressing H-RasV12 in a conditional manner were
treated with increasing concentrations of doxycycline.
Immunoblotting analysis showed that doxycycline at a
concentration of 0.5mg/ml was able to promote H-
RasV12 expression, which induced phosphorylation of
H2AX (Figure 4a). In addition, we performed pulse-
ﬁeld gel electrophoresis assay to analyze DNA fragmen-
tation in our model and detect DNA double-strand
breaks. The time course of H-RasV12 expression in
response to 1mg/ml of doxycycline was accompanied by
an increase in double-strand breaks and was correlated
to the increase of the phosphorylated form of histone
(g-H2AX) detected in the same conditions by western
blot analysis (Figure 4b). Immunoﬂuorescence micro-
scopy of HThy-ori cells transduced with H-RasV12
showed that g-H2AX foci-positive cells were also highly
positive for p22
phox (Figure 4c). Large fragments of
DNA visualized in pulse-ﬁeld gel electrophoresis
were not usually associated with apoptosis. This result
was strengthened by the absence of cell surface
expression of Annexin V, a marker of early-stage
apoptosis (Figures 5a and b).
ROS-generating NADPH oxidase NOX4 inactivation
abrogates H-RasV12-induced DNA-damage response and
subsequent senescence
To determine the role of NOX4 in DNA-damage
response induced by H-RasV12, we performed inter-
ference RNA experiments. H-RasV12–inducible cells
were treated for 48h with doxycycline in the presence of
NOX4 speciﬁc or p22
phox-speciﬁc siRNA and control
siRNA. A signiﬁcant reduction (40%) in DNA lesions
detected by H2A.X phosphorylation was observed after
Figure 4 Correlation between H-Ras expression level and DNA
damage. (a) Dose-dependent stimulation of g-H2A.X in Tet-
on-regulated H-RasV12 HThy-ori cells treated with doxycycline
for 48h. (b) Increase in DNA fragmentation level upon H-RasV12
activation. Kinetics of double-strand breaks increase measured by
pulse ﬁeld gel electrophoresis in cells after doxycycline treatment
(1mg/ml). Schizosaccharomyces pombe chromosomes are used as
DNA size markers. DNA fragmentation is analyzed on 1 million
and 2 millions cells as indicated. Time-dependent stimulation of
g-H2A.X in Tet-on-regulated H-RasV12 HThy-ori cells treated
with doxycycline (1mg/ml) for indicated times. (c) Immunoﬂuor-
escence of g-H2AX and p22
phox after expression of H-RasV12.
Magniﬁcation  10 (middle panel) and  100 (lower panel).
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Figure 5 H-Ras expression does not induce apoptosis in HThy-ori
cells. (a) Analysis of Annexin V staining upon H-RasV12-inducible
expression with doxycycline (1mg/ml). Cells were harvested on the
days indicated and analyzed for cell surface expression of annexin
V. (b) Hthy-ori cells treated with cisplatin (50mM) were used as
positive control.
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phox and NOX4 inactivation (Figure 6a). The same
results were obtained by immunoﬂuorescence analysis
where NOX4-inactivated cells displayed 50% reduction
of DNA-damage foci (Figures 6b and c). In addition,
NAC treatment of cells also signiﬁcantly decreased the
DNA-damage foci indicating involvement of H2O2 in
DNA lesions produced under H-RasV12 expression.
Taken together these data showed that NOX4-
dependent H2O2 generation participated in H-RasV12-
induced DNA-damage response.
As several studies suggested that DNA damage
response could also be triggered by excessive replication
caused by a sustained oncogenic signal (Bartkova et al.,
2006; Di Micco et al., 2006), we evaluated the role of
NOX4 in DNA replication rate induced by H-RasV12
by analysing the expression of CDC6, an essential
Figure 6 Inhibition of the NADPH oxidase NOX4 abrogates H-Ras-induced DNA-damage response. (a) NOX4 and p22
phox
knockdown with interference RNA decrease the level of H2A.X phosphorylation in Tet-on-regulated H-RasV12 HThy-ori cells treated
with doxycycline (1mg/ml) for 48h. Left panel: immunoblots for g-H2A.X, p22
phox and NOX4. b-Actin and total H2A.X were used as
loading control. Right panel: quantiﬁcation of g-H2A.X intensity by densitometry; *Po0.05, **Po0.01 using the Student’s t-test.
(b) Representative micrographs illustrating g-H2A.X staining in cells transduced with interference RNA against NOX4 or pretreated
with NAC (5mM) for 30min before addition of doxycycline (1mg/ml) for 48h. The nuclei were stained with DAPI (4’,6-diamidino-
2-phenylindole; blue). Magniﬁcation  63. (c) Quantiﬁcation of the number of g-H2A.X foci. Histogram indicates the number of cells
containing g-H2A.X foci among all cells stained with DAPI. The data represent the average and s.d. of three independent counts.
(d) Inhibition of NOX4 abrogates H-RasV12-induced CDC6 regulation. H-Ras and CDC6 were visualized by western blot in
H-RasV12-inducible cells treated with doxycycline (1mg/ml) for indicated times. b-Actin was used as loading control. All experiments
were realized with siRNA pool from Dharmacon (Table 1).
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Oncogeneregulator of DNA replication. We observed that H-
RasV12-inducible cells treated with doxycycline
displayed a transient increase in CDC6 expression
as compared with non-treated cells (Figure 6d),
NOX4 downregulation by RNA interference was
able to counteract H-RasV12-induced CDC6 upregula-
tion, suggesting that NOX4 might dampen DNA
replication rate.
It has been demonstrated that DNA-damage response
pathways have a major function in mediating senescence
(Bartkova et al., 2006; Mallette et al., 2007; Nuciforo
et al., 2007). As Ras-induced ROS production was
shown to be causative for senescence (Lee et al., 1999)
and in line with previous observations, we investigated
the involvement of NADPH oxidase NOX4 in Ras-
induced senescence. To characterize senescence signals,
we performed senescence-associated heterochromatin
foci (SAHF) assay as reported previously (Zhang
et al., 2005). Figure 7a shows that H-RasV12-inducible
cells treated with doxycycline for 6 days displayed an
increase in SAHF formation (0–25% cells) as compared
with non-treated cells (0–3% cells). p22
phox and NOX4
downregulation by RNA interference resulted in B60%
and 50% reduction of cells displaying SAHF, respec-
Figure 7 NADPH oxidase NOX4 is involved in H-RasV12-induced senescence. (a) Decrease in SAHF formation after NOX4
inactivation. Tet-on-regulated H-RasV12 HThy-ori cells were transduced with interference RNA against p22
phox or NOX4 and treated
or not with doxycycline (1mg/ml) for indicated times, ﬁxed and stained with DAPI (4’,6-diamidino-2-phenylindole). Magniﬁcation
 63. Results were quantiﬁed by scoring 100 cells on three independent slides for each assay from two independent experiments.
J3: sictrl vs sip22
phox P¼0.039, sictrl vs siNOX4 P¼0.048; J6: sictrl vs sip22
phox P¼0.349; sictrl vs siNOX4 P¼0.078 using Student’s
t-test. *Po0.05. Colocalizing HP1b/DAPI foci (b) and PML bodies (c) were quantiﬁed by scoring 100 cells from each slide. All
experiments were realized with siRNA NOX4 pool from Dharmacon (Table 1).
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Oncogenetively. HP1b and PML bodies largely described as
senescence markers were also analyzed. As described
previously (Zhang et al, 2005), HP1b colocalized with
SAHF in heterochromatin regions (Figure 7b) and PML
bodies become larger and more numerous as cells enter
senescence (Figure 7c). Once more, NOX4 inactivation
partly counteracts these effects, establishing a link
between H-RasV12 activation, H2O2-generating
NADPH oxidase NOX4 activation and senescence.
As cyclin-dependent kinase inhibitors p21
WAF (p21)
and p16
INK4A (Ink4a) are described to be crucial
mediators of senescence in response to oncogenic stress
(Collado and Serrano, 2006), we examined their expres-
sion upon H-RasV12 activation. The time course of H-
RasV12 expression ranging from 0 to 72h was
accompanied by p21 activation (Figure 8a). On the
other hand, p16
INK4A expression level did not show any
obvious difference indicating that it was not involved in
H-RasV12-induced senescence in our system. The
NADPH oxidase NOX4 inactivation was able to at
least partly counteract H-RasV12-induced p21 expres-
sion (Figure 8b) but failed to inhibit p16
INK4A.
HRasV12-induced senescence resulted in permanent
growth arrest as shown in Figure 8c. NOX4 down-
regulation by RNA interference inhibited the growth
arrest induced by oncogenic Ras.
Discussion
Although previous studies emphasized the role of ROS
in oncogene-induced DNA-damage response and senes-
cence (Lee et al., 1999; Mallette et al., 2007), there is
little demonstrated links between oncogenic activity,
ROS-generating systems and DNA-damage response. In
this study, we have demonstrated that oncogenic H-Ras
upregulates the NADPH oxidase NOX4 and its func-
tional partner p22
phox, which produce ROS and thereby
induce DNA damage and subsequently senescence.
Several reports have shown that oncogene over-
expression is accompanied by the presence of DNA
damage foci (Abulaiti et al., 2006; Mallette et al., 2007).
The lesions can be readily visualized using antibodies
against the phosphorylated form of the histone H2AX
(d’Adda di Fagagna et al., 2003). Using the HThy-ori3.1
cells expressing H-RasV12 in a conditional manner we
observed that H-RasV12 induced DNA damage as
shown by the presence of a nuclear focal pattern of
phosphorylated H2AX and promoted senescence by
affecting chromatin structure with the formation of
SAHFs. This effect was dependent on signal intensity.
By using a transgenic mouse model designed to express a
doxycycline-regulated mutant H-Ras allele, Sarkisian
et al. (2007) showed that the levels of Ras expression
correlated with the strength of the senescence response
(Sarkisian et al., 2007). Thus, high but not low levels of
activated H-Ras are able to trigger senescence in
mammary epithelial cells in vivo suggesting that a
second ‘‘hit’’ that causes increased levels of the mutant
Ras is required to trigger the senescence barrier.
Ampliﬁcation of Ras signaling has been reported
previously in a different setting (Quintanilla et al.,
1986) and also occurs when activated Ras is expressed
from its endogenous locus (Guerra et al., 2007).
Several mechanisms have been proposed to mediate
DNA damage response under oncogenic stimulation:
DNA damage response could be triggered by a
replicative stress caused by a sustained oncogenic signal
and/or could be caused by an oncogene-driven
accumulation of ROS. Oncogene-induced senescence
has been proposed to be triggered by accumulation of
Figure 8 NADPH oxidase NOX4 mediates H-RasV12-induced
cell proliferation arrest. (a) Induction of p21 by H-RasV12 in
thyroid cells. H-Ras, p16 and p21 were visualized by western blot in
Tet-on-regulated H-RasV12 HThy-ori cells treated with doxycy-
cline (1mg/ml) for indicated times. b-Actin was used as loading
control. (b) NOX4 inactivation abrogates H-Ras-induced p21
expression. Upper panel: immunoblots for p21 in Tet-on-regulated
H-RasV12 HThy-ori cells transduced with interference RNA
against NOX4 or pretreated with NAC (5mM, 30min) before
addition of doxycycline. Lower panel: quantiﬁcation of p21
intensity by densitometry; *Po 0,05 using Student’s t-test. (c) Cell
proliferation was evaluated by WST-1 assay as described in
Materials and methods. Immunoblot for NOX4 in these cells
transduced with different interference RNAs against NOX4.
According to cell proliferation experimental data, NOX4-3 siRNA
caused a more signiﬁcant reduction in NOX4 protein. These
experiments were realized with siRNA NOX4 pool and the three
stealth RNAi duplexes listed in Table 1. b-Actin was used as
loading control.
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OncogeneROS (Lee et al., 1999). Consistent with this hypothesis,
oncogene-induced senescence can be bypassed in murine
cells by growing cells in low oxygen (MacLaren et al.,
2004). Conversely, H2O2 is also a well-known senescence
trigger (Mallette et al., 2007). Notably, ROS scavengers
can suppress senescence in some systems (Lee et al.,
1999). In agreement with this, we measured by DCF
ﬂuorescence a ROS production induced by H-RasV12
expression in human thyroid cells, which caused DNA
lesions as revealed by quantiﬁcation of nuclear H2AX
foci. Treatment of cells with a ROS inhibitor, such as
NAC, signiﬁcantly inhibited DNA damage. Conse-
quently, these cells appeared to be a good experimental
model to characterize the mechanism by which H-
RasV12 induces ROS production.
NADPH oxidases are good candidates for ROS-
generating systems involved in senescence because
NIH3T3 ﬁbroblasts overexpressing transfected NOX4
were found to develop signs of cellular senescence
(Geiszt et al., 2000). In a recent study, we have
demonstrated the presence of NOX4 and its partner
p22
phox in human thyrocytes (Weyemi et al., 2010), which
are both positively regulated by the thyroid-stimulating
hormone. This NADPH oxidase was also found in this
study to be the only one expressed and induced by
HRasV12 in the HThy-ori3.1. To date, six homologs of
the phagocyte NADPH oxidase NOX2 (also known as
gp91phox) that generates O2
  and H2O2 have been
identiﬁed in many tissues. It appears that these enzymes
serve as a major source of intracellular ROS that has an
important signaling roles (Bedard and Krause, 2007).
The complexity of these isoforms in controlling ROS
production is increasingly apparent because each iso-
form has a unique expression pattern, subcellular
localization and subunits requirement. The NADPH
oxidase NOX4 has been originally identiﬁed in the
kidney and was shown to produce H2O2 continuously
(Geiszt et al., 2000). Association of NOX4 with p22
phox
seems to be a prerequisite for localization of the complex
to perinuclear vesicles (Serrander et al., 2007). In this
study, using immunoﬂuorescence, we found NOX4-
p22
phox complex localization in the endoplasmic reticu-
lum, but also in the nuclear membrane, in accordance
with previous studies (Hilenski et al., 2004; Kuroda
et al., 2005; Anilkumar et al., 2008). This perinuclear
localization suggested a potential role of NOX4 as a
DNA damage agent.
A direct link between the NADPH oxidase and DNA
damage was supported by the observation that siRNA-
mediated abrogation of NOX4 expression or its func-
tional partner p22
phox resulted in a signiﬁcant decrease in
DNA damage induced by H-RasV12 expression. Beside
producing oxidative DNA damage, it appears that
NOX4 might also produce DNA damage by increasing
the replication rate. CDC6 that has a key role in
regulating the initiation of DNA replication was found
in our study to be regulated by NOX4. As observed
previously, H-RasV12 led to a transient upregulation of
CDC6 (Di Micco et al., 2006), which was abrogated by
NOX4 inactivation. The weak expression of CDC6
observed for ﬁrst 24h could result from its degradation
that has been described in early phase of replication
(Petersen et al., 2000). NOX4 inactivation might
prevent this process. Interestingly, in a recent study, a
novel regulator of NOX4, Poldip2 has been identiﬁed
(Lyle et al., 2009). This protein was originally identiﬁed
as a proliferating cell nuclear antigen and DNA
polymerase d-interacting protein, suggesting a possible
function in the nucleus in relation to DNA (Liu et al.,
2003).
It has been suggested that DNA damage may precede
and trigger SAHF formation (Hemann and Narita,
2007). Interestingly, in this study we show that suppres-
sion of the NADPH oxidase NOX4-p22
phox expression
impaired both DNA damage and SAHF formation. The
intensity of SAHF formation was shown to be different
depending on the senescence stimulus and the cell type
(Hemann and Narita, 2007). Although SAHFs are
induced by a variety of stimuli, oncogenic Ras was
shown to induce SAHFs most prominently, suggesting
that there might be a threshold level of DNA damage
above which SAHF formation is triggered. This could
be also related to the level of NOX4 expression and
consequently to its activity. Previous studies have
focused on transcriptional control of NOX4 as the
principal mechanism of regulation (Serrander et al.,
2007). Importantly, we observed a regulation of NOX4
transcription by H-RasV12. We cannot however exclude
other mechanisms of regulation.
Activation and/or increased expression of other
components of the H-Ras pathway, such as Rac1,
induced cellular senescence (Debidda et al., 2006).
Several studies have implicated Rac-mediated produc-
tion of ROS in a variety of cellular response and, in
some endogenously NOX4-expressing cells, a Rac
requirement for the NOX4-mediated ROS production
has been shown (Gorin et al., 2003). Moreover,
increased expression of E2F transcription factors led
also to premature senescence (Johnson and Degregori,
2006) and E2F factor(s) were recently shown to be
positive regulators of NOX4 transcription in vascular
smooth muscle cells (Zhang et al., 2008). Taken together
these data suggest that NOX4 induced from distinct
oncogenes could be a common genotoxic agent implied
in senescence.
Oncogenic Ras is believed to have roles in the
initiation and progression of thyroid tumors, based on
the high frequency of Ras mutations found in benign
and malignant thyroid tumors (Suarez et al., 1990;
Tallini, 2002). However, it has also been shown that a
telomere-independent mechanism in limiting H-RasV12
oncogene-driven proliferation of human thyroid epithe-
lial cells can take place (Jones et al., 2000). Senescence is
accompanied by upregulation of cyclin-dependent ki-
nase inhibitors p21 and p16. In this study, H-RasV12
induced p21 expression and, treatment with NAC or
siRNA-mediated abrogation of NOX4 expression in-
hibited p21 induction indicating that ROS produced via
NOX4 regulated p21 expression. By contrast, there
was no sign of p16 induction. Therefore, in agreement
with previously published data obtained with human
ovarian surface epithelial cells, inducible expression
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Oncogeneof H-Ras in these human thyroid cells led to senescence
by a mechanism that did not involve p16 (Nicke et al.,
2005).
Our work demonstrates for the ﬁrst time a crucial role
for NOX4 in DNA damage induced by oncogenic H-
Ras and consequently in the senescence process. Several
reports have demonstrated that senescence is not merely
an artifact of cell culture but occurs in vivo to limit
tumor growth in mice and humans. DNA damage foci
have been identiﬁed in early tumor precursor lesions and
are proposed to occur as a consequence of activated
oncogenes (Bartkova et al., 2005). It has been suggested
that ROS could induce and maintain senescence-
induced tumor suppression (Takahashi et al., 2006).
Thus, if function for ROS is to enforce irreversible
cellular senescence, the NADPH oxidase NOX4, as
ROS-generating system, appears to be a potential
contributor to tumor suppression.
Materials and methods
Plasmids, cells and stable transfection
The human thyroid epithelial cell line (HThy-ori) was obtained
from American Type Culture Collection and cultured in RPMI
1640 medium supplemented with 1% antibiotics–antimicotics
(Invitrogen, Carlsbad, CA, USA), 2mM of L-glutamine
(Invitrogen), 10% fetal calf serum (PAA Laboratories,
Pasching, Austria) and maintained at 371C in a 5% CO2—
95% O2 mixture. H-Ras cDNA was isolated by a RT–PCR
procedure using AmpliTaq Gold’s protocol (Applied Biosys-
tems, Foster City, CA, USA) and using total RNA isolated
from human thyrocytes as a template. Primers were 50-
ATGACGGAATATAAGCTGGTGGT-30 and 50-TCAGGA
GAGCACACACTTGCAGCT-30 with EcoR1 sites added.
The cDNA was cloned into the EcoRI sites of the tetracy-
cline-inducible vector pcDNA4/TO (Invitrogen) and se-
quenced. The H-Ras mutant (H-RasV12) was generated by
replacing glycine 12 by valine using the QuickChange Site-
Directed Mutagenesis kit (Stratagene, La Jolla, CA, USA) and
sequenced. To obtain tetracycline-inducible cell lines,
pcDNA4TO-HRasV12 and pcDNA6/TR expressing the tetra-
cycline (Tet) repressor (Invitrogen) were transfected into
HThy-ori cells using FuGENE 6 (Roche Applied Science,
Indianapolis, IN, USA) and the cells were selected for
resistance to zeocine (100mg/ml) and blasticidine (10mg/ml)
for 20–30 days. Tet-on-regulated H-RasV12 HThy-ori cells
were cultured in RPMI 1640 medium supplemented with Tet-
free fetal calf serum (PAA laboratories).
Real-time–PCR
Total RNA from cells was extracted using Trizol reagent
(Invitrogen, Inc.) according to the manufacturer’s instructions.
Quality of RNA preparation, based on the 28S/18S ribosomal
RNAs ratio, was assessed using the RNA 6000 Nano Lab-On-
chip (Agilent Technologies, Palo Alto, CA, USA). Reverse
transcription and real-time–PCR were performed as described
previously (Weyemi et al., 2010). Oligonucleotides were
purchased from MWG Biotech (Courtaboeuf, Les Ulis,
France) and their sequences are available on demand.
Transient transfection
Tet-on-regulated H-RasV12 HThy-ori cells were transfected at
60% conﬂuence with small interference RNA against NOX4
and p22
phox listed in Table 1 or scrambled siRNA control (
Dharmacon, Lafeyette, CO, USA) by using the Jet Pei
transfection reagent (Polyplus-Ozyme, Saint Quentin en
Yvelines Cedex, France). Cells were incubated for 8h with
siRNA-Jet Pei complex in RPMI 1640 medium supplemented
with 0.2% Tetracycline-free fetal calf serum; 1mg/ml doxycy-
cline was then added to medium for 48h. The knockdown
efﬁciency was checked by qPCR and immunoblot assays. The
pcDNA4TO-H-RasV12 vector and the pHyPer-nuc vector
(Evrogen JSC, Moscow, Russia) were transiently transfected,
respectively, into Tet-on-regulated H-RasV12 HThy-ori cells
using the Jet Pei transfection reagent (Polyplus) according to
the manufacturer’s protocol.
Immunoﬂuorescence
Cells were plated at 2 10
5/well in 6-well plates in RPMI 1640
medium as described in cell cultures. Cells were ﬁxed for
30min with freshly prepared 4% paraformaldehyde in
phosphate-buffered saline (PBS). After washing with PBS,
the cells were permeabilized for 10min in PBS plus sodium
dodecyl sulfate 0.1%. The cells were then blocked with 10%
fetal calf serum for 30min and incubated for 1h at room
temperature with primary antibody diluted in PBS plus 0.1%
bovine serum albumin: p22
phox (sc-20781 Santa Cruz Biotech-
nology, Santa Cruz, CA, USA); NOX4 (CO 80160, Novus
Table 1 Sequences of selected siRNA against NOX4 and p22
phox
Product (manufacturer) Name of siRNA Sequence
siNOX4 NOX4-1 50-ACUAUGAUAUCUUCUGGUA-30
SMARTpool (Dharmacon) NOX4-2 50-GAAAUUAUCCCAAGCUGUA-30
NOX4-3 50-GGGCUAGGAUUGUGUCUAA-30
NOX4-4 50-GAUCACAGCCUCUACAUAU-30
sip22
phox pool (Dharmacon) p22
phox-1 50-CCAUGUGGGCCAACGAACA-30
p22
phox-2 50-GAAGAAGGGCUCCACCAUG-30
p22
phox-3 50-GUACAUGACCGCCGUGGUG-30
p22
phox-4 50-UACCAGGAAUUACUAUGUU-30
Stealth RNAi duplex (Invitrogen) NOX4-1 50-GGAGAACCAGGAGAUUGUUGGAUAA-30
50-UUAUCCAACAAUCUCCUGGUUCUCC-30
NOX4-2 50-AGAGUGAAGACUUUGUUGAACUGAA-30
50-UUCAGUUCAACAAAGUCUUCACUGU-30
NOX4-3 50-CCUCAUGAUCACAGCCUCUACAUAU-30
50-AUAUGUAGAGGCUGUGAUCAUGAGG-30
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Billerica, MA, USA); calreticulin (ab2907, Abcam, Cam-
bridge, MA, USA); green ﬂuorescent protein (11814460001
Roche); HP-1b (MAB3448, Millipore); PML (sc-5621 Santa
cruz). After washing in PBS plus 0.1% bovine serum albumin,
the cells were stained with an Alexa ﬂuor 488 or Alexa ﬂuor
568 antibody (Invitrogen) for 1h at room temperature.
Finally, the cells were washed in PBS and coverslips were
mounted for analysis. Fluorescent images were captured using
a confocal microscope (Leica DM IRE 2, Perkin Elmer,
Waltham, MA, USA).
Intracellular ROS detection
Intracellular ROS levels were measured by ﬂow cytometry in
cells loaded with the redox-sensitive dye DCFH-DA (Invitro-
gen, Molecular probe) as described previously (Weyemi et al.,
2010).
pHyPer-transfected cells were plated to glass-bottom dishes,
treated with doxycycline (1mg/ml) and analyzed by confocal
microscopy. The ﬂuorescence (excitation/emission: 488/
530nm) was examined under an LSM 510 confocal microscope
(Zeiss, Jena, Germany).
Pulsed-ﬁeld gel electrophoresis
Cells were washed once with ice-cold PBS, trypsinized and
included into agarose plugs. Plugs were prepared by adding
equal volume of cell samples (at the concentration of 2 10
6
cells/ml) to low-melting-point agarose (0.5ml, 1.6%) and let
set for 1h at 41C. Plugs were then placed in 1.5ml of lysis
solution (0.5 M EDTA at pH 7.6, 2% sarkosyl, 1% proteinase
K and 2mM deferoxamine) and incubated at 501C for 38h
(Boucher et al., 2006). After two washes with TE (10mM Tris–
HCl, 1mM EDTA, pH 7.6) containing 0.1mM deferoxamine
and a 1-h incubation at room temperature with TE-0.1mM
PMSF, plugs were stored at 41C in 0.05 M EDTA and 0.1mM
deferoxamine. Pulse-ﬁeld gel electrophoresis was performed
with a neutral 0.7% agarose gel in Tris-acetic acid-EDTA
buffer using clamped homogenous electric ﬁelds-Mapper
(Bio-Rad, Marnes-la-Coquette, France), for 74-h running time
at 2V/cm with a reorientation angle (1061) and a 35-min pulse
switch time.
Nuclei extraction
Nuclei were extracted using Nuclei EZ prep nuclei isolation kit
(Sigma-Aldrich, St Louis, MO, USA) according to the
manufacturer’s instructions. Brieﬂy, cells were harvested and
lysed on ice with Nuclei EZ lysis buffer. Nuclei were collected
by centrifugation at 500g for 5min at 41C. The clear
supernatant was submitted to centrifugation at 200000g. The
detergent-insoluble pellet and the nuclei pellet were resus-
pended in modiﬁed RIPA buffer (0.025 M Tris/HCl pH 7.4,
0.15 M NaCl, 0.5% Triton X-100, 0.1% sodium dodecyl
sulfate, 0.1% sodium deoxycholate and protease inhibitor
cocktail (Sigma)) for western blot analysis. Quality and
integrity of nuclei fraction were analyzed by microscopy after
4’,6-diamidino-2-phenylindole staining.
Cell survival test
Cell proliferation/viability of H-RasV12-inducible HThy-ori
cells (24-well plates; 10
4cells/well) was assayed using the
WST-1 assay according to the manufacturer’s instructions.
Cells were transduced with siRNA control or siRNA against
NOX4 24h before treatment with doxycycline (1mg/ml) for
indicated times.
Annexin V staining
Cells were suspended in binding buffer (BD Pharmingen, San
Diego, CA, USA) and stained with FITC Annexin V (1/20) in
binding buffer for 15min at room temperature in the dark.
Cells were resuspended in 400ml binding buffer and immedi-
ately analyzed by FACSCalibur (BD Biosciences, San Diego,
CA, USA).
Western blots
Cells were washed twice with PBS, directly solubilized in
denaturing sample buffer and then subjected to sodium
dodecyl sulfate–polyacrylamide gel electrophoresis as de-
scribed previously (Moskaluk et al., 2002). Proteins were
electrotransferred to 0.2mm Protan BA 83 (Schleicher and
Schuell, Mantes la ville, France) for immunodetection.
Primary antibodies: NOX4 (CO 80160, Novus biologicals);
p22
phox (sc-20781 Santa Cruz Biotechnology); g-H2A.X (05-
636, Millipore); p21 (sc-397 Santa Cruz Biotechnology); H-
Ras (sc-520 Santa Cruz Biotechnology); green ﬂuorescent
protein (11814460001 Roche); CDC6 (3387S Cell Signaling,
Danvers, MA, USA). Immune complexes were detected with
horseradish peroxidase coupled anti-rabbit IgG antibody
(Southern Biotech, Birmingham, AL, USA).
Immunohistochemistry
H-RasV12-inducible HThy-ori cells and NOX4-inducible
HEK293 cells (kindly given by Karl-Heinz Krause (University
of Geneva, Switzerland)) were pelleted by centrifugation
and the media carefully aspirated. Formaldehyde was
carrefully added to the tube. The cell pellet was allowed to
ﬁx overnight at 41C. The formaldehyde was removed, and
the cell pellet was carefully dislodged. Before processing,
30ml of standard 2% agarose was poured into a 100mm
bacterial petri dish and allowed to set. Doughnut-shaped
agarose molds were made by making concentric circles in the
agarose. The ﬁxed cell pellets were packed into the center of
the molds with a small spatula. The processed plugs were then
embedded in parafﬁn. Immunohistochemical study was
performed on formaldehyde-ﬁxed, parafﬁn-embedded cells as
described previously (Weyemi et al, 2010). Sections were
incubated for 60min at room temperature with the rabbit
polyclonal anti-NOX4 antiserum (1:100), they were then
washed in Tris–HCl 1  buffer for 5min and incubated
with a peroxidase-conjugated goat anti-rabbit antibody
for 30min (ENVISION; DAKO Corp., Carpinteria, CA,
USA). After further washes, peroxidase staining was revealed
in diaminobenzidine tetrahydrochloride (Polysciences Inc.,
Warrington, PA, USA) with 0.1% (w/v) of hydrogen peroxide,
in Tris buffer, 0.01mol/l (pH 7.2). Sections were counter-
stained and mounted. Negative controls were obtained by
replacing the speciﬁc primary antibody by an irrelevant
antibody.
Statistical analysis
The tests were performed using the GraphPadInstat software
(GraphPad, La Jolla, CA, USA) for analysis of variance,
and Student’s t-test with the level of signiﬁcance set at
Po0.05.
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